Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
5,753
Views
15
CrossRef citations to date
0
Altmetric
Oncology
Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer
Julie Vanderpoela Janssen Scientific Affairs, LLC, Horsham, PA, USA
https://orcid.org/0000-0001-5055-6216
Andrea L. Stevensb Janssen Global Services, Inc, Raritan, NJ, USA
https://orcid.org/0000-0002-2892-7065
Bruno Emondc Analysis Group, Inc, Montréal, Québec, Canada
https://orcid.org/0000-0002-0060-765X
Marie-Hélène Lafeuillec Analysis Group, Inc, Montréal, Québec, Canada
, Annalise Hiltsc Analysis Group, Inc, Montréal, Québec, Canada
, Patrick Lefebvrec Analysis Group, Inc, Montréal, Québec, Canada
& Laura Morrisonc Analysis Group, Inc, Montréal, Québec, CanadaCorrespondence[email protected]
show all
Pages 457-468
|
Received 10 Feb 2022, Accepted 11 Mar 2022, Published online: 30 Mar 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.